EyeGate Pharmaceuticals Inc buy Quitte
Start price
30.01.17
/
50%
€24.62
Target price
22.02.17
€2.44
Performance (%)
49.99%
End price
22.02.17
€36.94
Summary
This prediction ended on 22.02.17 with a price of €36.94. With a performance of 49.99% the BUY prediction by Quitte was a big success. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
EyeGate Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by Quitte for this prediction
In the thread EyeGate Pharmaceuticals Inc diskutieren
was auf die Augen
ein Versuch ist es wert
http://crweworld.com/article/press-releases/56356/eyegate-pharma-announces-positive-top-line-data-from-first-in-human-pilot-trial-of-ocular-bandage-gel-in-corneal-epithelial-defects
(Zielkurs erreicht)